{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T02:50:35Z","timestamp":1794538235726,"version":"4.9.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,12,27]],"date-time":"2016-12-27T00:00:00Z","timestamp":1482796800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS J"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1208\/s12248-016-0013-0","type":"journal-article","created":{"date-parts":[[2016,12,27]],"date-time":"2016-12-27T12:32:57Z","timestamp":1482841977000},"page":"520-526","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Tissue Concentration of Dodecafluoropentane (DDFP) Following Repeated IV Administration in the New Zealand White Rabbit"],"prefix":"10.1208","volume":"19","author":[{"given":"Christine","family":"Arthur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Culp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aliza","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Borrelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Skinner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard","family":"Hendrickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,12,27]]},"reference":[{"issue":"5","key":"13_CR1","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.jstrokecerebrovasdis.2013.07.019","volume":"23","author":"MJ Lyerly","year":"2014","unstructured":"Lyerly MJ, Albright KC, Boehme AK, Bavarsad Shahripour R, Houston JT, Rawal PV, et al. Safety of protocol violations in acute stroke tPA administration. J Stroke Cerebrovasc Dis. 2014;23(5):855\u201360.","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"5","key":"13_CR2","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.3171\/2012.11.JNS12408","volume":"118","author":"RC Turner","year":"2013","unstructured":"Turner RC, Dodson SC, Rosen CL, Huber JD. The science of cerebral ischemia and the quest for neuroprotection: navigating past failure to future success. J Neurosurg. 2013;118(5):1072\u201385.","journal-title":"J Neurosurg"},{"issue":"2","key":"13_CR3","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1586\/ern.11.198","volume":"12","author":"PD Schellinger","year":"2012","unstructured":"Schellinger PD, Kohrmann M. Current acute stroke trials and their potential impact on the therapeutic time window. Expert Rev Neurother. 2012;12(2):169\u201377.","journal-title":"Expert Rev Neurother"},{"issue":"1","key":"13_CR4","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jvir.2011.10.001","volume":"23","author":"WC Culp","year":"2012","unstructured":"Culp WC, Woods SD, Skinner RD, Brown AT, Lowery JD, Johnson JL, et al. Dodecafluoropentane emulsion decreases infarct volume in a rabbit ischemic stroke model. J Vasc Interv Radiol. 2012;23(1):116\u201321.","journal-title":"J Vasc Interv Radiol"},{"key":"13_CR5","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2174\/1874205X01408010027","volume":"8","author":"AT Brown","year":"2014","unstructured":"Brown AT, Arthur MC, Nix JS, Montgomery JA, Skinner RD, Roberson PK, et al. Dodecafluoropentane emulsion (DDFPe) decreases stroke size and improves neurological scores in a permanent occlusion rat stroke model. Open Neurol J. 2014;8:27\u201333.","journal-title":"Open Neurol J"},{"key":"13_CR6","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1423-0410.2006.00789.x","volume":"91","author":"RM Winslow","year":"2006","unstructured":"Winslow RM. Current status of oxygen carriers (\u2018blood substitutes\u2019): 2006. Vox Sang. 2006;91:102\u201310.","journal-title":"Vox Sang"},{"issue":"1","key":"13_CR7","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1081\/BIO-200046659","volume":"33","author":"JG Riess","year":"2005","unstructured":"Riess JG. Understanding the fundamentals of perfluorocarbons and perfluorocarbon emulsions relevant to in vivo oxygen delivery. Artif Cells Blood Substit Immobil Biotechnol. 2005;33(1):47\u201363.","journal-title":"Artif Cells Blood Substit Immobil Biotechnol"},{"issue":"4","key":"13_CR8","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1080\/10731190903043192","volume":"37","author":"JL Johnson","year":"2009","unstructured":"Johnson JL, Dolezal MC, Kerschen A, Matsunaga TO, Unger EC. In vitro comparison of dodecafluoropentane (DDFP), perfluorodecalin (PFD), and perfluoroctylbromide (PFOB) in the facilitation of oxygen exchange. Artif Cells Blood Substit Immobil Biotechnol. 2009;37(4):156\u201362.","journal-title":"Artif Cells Blood Substit Immobil Biotechnol"},{"issue":"4","key":"13_CR9","first-page":"215","volume":"32","author":"C Lundgren","year":"2005","unstructured":"Lundgren C, Bergoe G, Olszowka A, Tyssebotn I. Tissue nitrogen elimination in oxygen-breathing pigs is enhanced by fluorocarbon-derived intravascular micro-bubbles. Undersea Hyperb Med. 2005;32(4):215\u201326.","journal-title":"Undersea Hyperb Med"},{"issue":"2","key":"13_CR10","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s12035-013-8495-6","volume":"48","author":"SD Woods","year":"2013","unstructured":"Woods SD, Skinner RD, Ricca AM, Brown AT, Lowery JD, Borrelli MJ, et al. Progress in dodecafluoropentane emulsion as a neuroprotective agent in a rabbit stroke model. Mol Neurobiol. 2013;48(2):363\u20137.","journal-title":"Mol Neurobiol"},{"issue":"2","key":"13_CR11","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.mri.2014.10.012","volume":"33","author":"RT Fitzgerald","year":"2015","unstructured":"Fitzgerald RT, Ou X, Nix JS, Arthur MC, Brown AT, Skinner RD, et al. Dodecafluoropentane emulsion delays and reduces MRI markers of infarction in a rat stroke model: a preliminary report. Magn Reson Imaging. 2015;33(2):236\u20139.","journal-title":"Magn Reson Imaging"},{"issue":"5","key":"13_CR12","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1152\/jappl.1995.79.5.1777","volume":"79","author":"EC Johnson","year":"1995","unstructured":"Johnson EC, Erickson BK, Podolsky A, Birks EK, Keipert PE, Faithfull NS, et al. Effects of a perfluorocarbon emulsion for enhanced O2 solubility on hemodynamics and O2 transport in dogs. J Appl Physiol (1985). 1995;79(5):1777\u201386.","journal-title":"J Appl Physiol (1985)"},{"issue":"9","key":"13_CR13","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1002\/jssc.201000921","volume":"34","author":"L Kovatsi","year":"2011","unstructured":"Kovatsi L, Giannakis D, Arzoglou V, Samanidou V. Development and validation of a direct headspace GC-FID method for the determination of sevoflurane, desflurane and other volatile compounds of forensic interest in biological fluids: application on clinical and post-mortem samples. J Sep Sci. 2011;34(9):1004\u201310.","journal-title":"J Sep Sci"},{"key":"13_CR14","volume-title":"Laboratory animal medicine","year":"1984","unstructured":"Fox JG, Cohen BJ, Loew FM, editors. Laboratory animal medicine. Orlando: Academic; 1984."},{"issue":"4","key":"13_CR15","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0301-5629(00)00363-X","volume":"27","author":"JM Correas","year":"2001","unstructured":"Correas JM, Meuter AR, Singlas E, Kessler DR, Worah D, Quay SC. Human pharmacokinetics of a perfluorocarbon ultrasound contrast agent evaluated with gas chromatography. Ultrasound Med Biol. 2001;27(4):565\u201370.","journal-title":"Ultrasound Med Biol"},{"issue":"4","key":"13_CR16","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.3109\/10731199409138801","volume":"22","author":"SF Flaim","year":"1994","unstructured":"Flaim SF. Pharmacokinetics and side effects of perfluorocarbon-based blood substitutes. Artif Cells Blood Substit Immobil Biotechnol. 1994;22(4):1043\u201354.","journal-title":"Artif Cells Blood Substit Immobil Biotechnol"},{"issue":"4","key":"13_CR17","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.3109\/10731199409138812","volume":"22","author":"PE Keipert","year":"1994","unstructured":"Keipert PE, Otto S, Flaim SF, Weers JG, Schutt EA, Pelura TJ, et al. Influence of perflubron emulsion particle size on blood half-life and febrile response in rats. Artif Cells Blood Substit Immobil Biotechnol. 1994;22(4):1169\u201374.","journal-title":"Artif Cells Blood Substit Immobil Biotechnol"},{"issue":"5","key":"13_CR18","first-page":"365","volume":"45","author":"JG Riess","year":"1988","unstructured":"Riess JG. Blood substitutes: where do we stand with the fluorocarbon approach? Curr Surg. 1988;45(5):365\u201370.","journal-title":"Curr Surg"},{"issue":"5","key":"13_CR19","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/0735-1097(95)00306-1","volume":"26","author":"PA Grayburn","year":"1995","unstructured":"Grayburn PA, Erickson JM, Escobar J, Womack L, Velasco CE. Peripheral intravenous myocardial contrast echocardiography using a 2% dodecafluoropentane emulsion: identification of myocardial risk area and infarct size in the canine model of ischemia. J Am Coll Cardiol. 1995;26(5):1340\u20137.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"13_CR20","doi-asserted-by":"crossref","first-page":"523","DOI":"10.2217\/nnm.10.23","volume":"5","author":"S Nie","year":"2010","unstructured":"Nie S. Understanding and overcoming major barriers in cancer nanomedicine. Nanomedicine (Lond). 2010;5(4):523\u20138.","journal-title":"Nanomedicine (Lond)"},{"key":"13_CR21","first-page":"38","volume":"16","author":"DR Spahn","year":"2001","unstructured":"Spahn DR, Pasch T. Physiological properties of blood substitutes. News Physiol Sci. 2001;16:38\u201341.","journal-title":"News Physiol Sci"},{"issue":"2","key":"13_CR22","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1046\/j.1537-2995.1998.38298193096.x","volume":"38","author":"OP Habler","year":"1998","unstructured":"Habler OP, Kleen MS, Hutter JW, Podtschaske AH, Tiede M, Kemming GI, et al. Hemodilution and intravenous perflubron emulsion as an alternative to blood transfusion: effects on tissue oxygenation during profound hemodilution in anesthetized dogs. Transfusion. 1998;38(2):145\u201355.","journal-title":"Transfusion"}],"container-title":["The AAPS Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-016-0013-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1208\/s12248-016-0013-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-016-0013-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,16]],"date-time":"2019-09-16T20:36:17Z","timestamp":1568666177000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1208\/s12248-016-0013-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,27]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["13"],"URL":"https:\/\/doi.org\/10.1208\/s12248-016-0013-0","relation":{},"ISSN":["1550-7416"],"issn-type":[{"value":"1550-7416","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,27]]}}}